A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

In Sept. 23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady ...

Sulfonylureas, short-acting, and medium-acting insulins for the treatment of diabetes mellitus type 2 may increase the risk of diabetic retinopathy, while fibrates and Cox-2 inhibitors may decrease it ...

Nurse giving blood sugar test to patient in home This study builds on recent research indicating that prescribing NPH insulin may be reasonable for older patients with concerns about medication costs, ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and ...

(AP) - Another major insulin maker has promised steep price cuts, as pressure grows on drugmakers and insurers to trim the cost of a medication that millions of Americans need. Novo Nordisk said ...

Novo Nordisk plans to slash the U.S. list prices for several of its insulin drugs by as much as 75%, the company said on Tuesday. The move follows Eli Lilly's announcement earlier this month that it ...